TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

NCT01564095 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

TERMINATED

Status

25

Enrollment

OTHER

Sponsor class

Stopped Missing evidence of the effectiveness of the study medication

Conditions

Terminal Liver Disease
Ischemia Reperfusion Injury
Graft Dysfunction
Graft Failure
Poor Graft Quality

Interventions

DRUG: Tacrolimus
DRUG: HTK/Placebo

Sponsor

Ludwig-Maximilians - University of Munich